Neuralace Medical

02/23/2026

Thank you to CALSIPP 2026 for the opportunity to connect and exchange insights on the evolving role of magnetic peripheral nerve stimulation (mPNS) in chronic neuropathic pain care.

Conversations with leaders in interventional pain medicine continue to shape thoughtful dialogue around non-invasive neuromodulation and its place in today’s treatment landscape.

Appreciation to Taylor Clarkin, Sean Bartlett, and Dr. Marshall Bedder for representing Neuralace Medical.

02/20/2026

Great conversations at CALSIPP 2026.

Dr. Marshall Bedder welcomed Dr. Howard Rosner to the Neuralace Medical booth to discuss the expanding role of non-invasive neuromodulation in chronic neuropathic pain care.

Engaging with leaders in interventional pain management helps advance thoughtful dialogue around magnetic peripheral nerve stimulation (mPNS) and its place in today’s treatment landscape.

Appreciate the visit at California Society of Interventional Pain Physicians and the opportunity to exchange insights.

02/19/2026

Chronic nerve pain can impact every part of daily life. That’s why we continue to invest in education and awareness for both patients and providers.

Axon Therapy® mPNS is changing lives every day without needles, scalpels, implants, or ablations.

This weekend, our team will be at CALSIPP 2026 sharing advancements in non-invasive pain treatment using Axon® Therapy, a painless and non-invasive mPNS treatment for chronic neuropathic pain.

Learn more about our 100% non-invasive mPNS treatment for chronic neuropathic pain: neuralacemedical.com/patients

02/02/2026

Axon Therapy® mPNS in Mexico City!

Sharon Waiss, Director, with Marshall Bedder, MD at Hospital Ángeles Lomas, alongside the rehabilitation leadership team.

Hospital Ángeles Lomas is part of the Hospital Angeles Health System, Mexico’s largest private hospital network, with nearly 30 locations nationwide delivering specialized, high-quality care. The system is also a leading destination for medical tourism, offering advanced technologies and bilingual services for international patients.

Expanding access to non-invasive neuromodulation through global clinical collaboration. Visit https://neuralacemedical.com/ to learn more.

01/24/2026

From founding NANS to shaping what’s next in neuromodulation!

A quick conversation with Drs. Marshall Bedder and Joshua Prager at NANS 2026—proof the field continues to move forward.

01/23/2026

We’re live at NANS 2026!

Visit the Neuralace booth  #611 to learn about Axon Therapy® mPNS, our non-invasive neuromodulation option for chronic neuropathic pain.

Stop by, ask questions, and connect with the team.

01/16/2026

The Axon Therapy® mPNS patient trial is underway at Integrity Pain and Wellness in Prescott, AZ.

Working alongside Dr. Amit Patel and the Integrity Pain and Wellness team, Dr. Marshall Bedder, Joe Milkovits, Sean Bartlett, and Christopher Morano from Neuralace Medical are supporting the introduction of this non-invasive neuromodulation therapy into clinical practice.

01/13/2026

Access to non-invasive neuromodulation continues to expand — now available to patients in Charleston, South Carolina.

Axon Therapy® mPNS is now offered at DeNovo Pain Management with Dr. David Arcella, bringing this FDA-cleared therapy to patients living with chronic neuropathic pain.

Our magnetic Peripheral Nerve Stimulation (mPNS) therapy is designed to help reduce pain symptoms without drugs, injections, implants, or surgery.

Learn more about Axon Therapy® at neuralacemedical.com.

01/12/2026

We’re pleased to share that Marshall Bedder, MD, has been appointed Chief Medical Officer at Neuralace Medical®, transitioning from his role as Chairman of the Medical Advisory Board.

“Neuralace Medical represents the future of pain care. I feel incredibly fortunate to be part of a company that champions technology delivering meaningful results without additional pain or side effects. The focus on cost-effective therapy that reduces overall healthcare expenditures while successfully treating intractable pain is what truly sets this work apart.”

Dr. Bedder is an ABA-certified anesthesiologist with added qualifications in Pain Medicine, board certified in Addiction Medicine, and the founder of two ABMS- and ABPM-certified pain fellowship programs. He brings extensive experience as a medical director across multiple care settings and a long-standing commitment to evidence-based, patient-centered neuromodulation.

His transition into the Chief Medical Officer role reflects both his leadership within the organization and Neuralace Medical’s continued focus on clinical rigor, safety, and long-term outcomes.

Welcome to the team, Dr. Bedder!

Visit https://neuralacemedical.com to learn more.

12/16/2025

Our study, Safety and Efficacy of Magnetic Peripheral Nerve Stimulation for Treating Painful Diabetic Neuropathy, continues to be recognized in the peer-reviewed literature, including Neuromodulation: Technology at the Neural Interface.

“Magnetic peripheral nerve stimulation (mPNS) is the gateway Neuromodulation therapy that is noninvasive, cost-effective therapy not only for painful diabetic neuropathy (PDN) but also for post-traumatic and post-operative chronic neuropathic pain. The results rival those of spinal cord stimulation (SCS) for DPN without any complications reported in over 5,000 treatments.” — Marshall Bedder MD, Chief Medical Officer, Neuralace Medical

For clinicians treating painful diabetic neuropathy and chronic neuropathic pain, this publication adds meaningful long-term data to the evolving neuromodulation landscape.

Read the full peer-reviewed article: www.neuromodulationjournal.org/article/S1094-7159(25)00138-2/fulltext

12/11/2025

Access to non-invasive neuromodulation continues to grow across the US and is now available to patients in Wisconsin.

Axon Therapy® mPNS is now available at Alleviate Pain & Spine in De Pere, WI, led by Dr. Mansoor Aman, Dr. Ammar Mahmoud, and Dr. Vishal Patel.

This FDA-cleared, 100% non-invasive therapy is designed to help patients with chronic neuropathic pain reduce symptoms without drugs, injections, implants, or surgery.

Learn more about Axon Therapy® at neuralacemedical.com.

12/09/2025

Axon Therapy® mPNS is now available in Fort Lauderdale, Florida!

Anthony Giuffrida, MD and the team at Cantor Spine are excited to provide patients in South Florida with magnetic Peripheral Nerve Stimulation (mPNS), our 100% non-invasive, FDA-cleared treatment for chronic neuropathic pain.

Magnetic PNS (mPNS) is here! Our patients now have access to a noninvasive, FDA-cleared treatment for chronic nerve pain with NO implants, NO injections, NO needles, and NO surgery!

Axon Therapy's breakthrough therapy uses magnetic pulses to target nerves and help the body retrain how it processes pain, offering lasting relief without downtime or risk of infection.